glp-1 drugs moa and Anesthesia: Considerations and Cautions for CRNAs DPP4 Inhibitors vs GLP-1 Agonists

Dietary Supplements for Weight Loss

doi: 10.1007/S00592-023-02124-W 40 AnholmCKumarathuraiPPedersenLRSamkaniAWalzemRLNielsenOWet al

GLP1/E ameliorates also ovarian cyclicity in an ovulatory model of PCOS, without direct estrogenic uterotrophic effects

In addition, G protein-coupled excitatory GLP-1 receptors are located in central regions subserving disparate brain functions (eg, ventral tegmental area, nucleus accumbens, hippocampus, lateral septum, hypothalamus)

GLP-1 weight-loss drugs pose hidden risks for young women Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy and unborn babies, warn Flinders University researchers